Patents Represented by Attorney, Agent or Law Firm Kevin R. Kaster
-
Patent number: 5384261Abstract: A method and device for forming large arrays of polymers on a substrate (401). According to a preferred aspect of the invention, the substrate is contacted by a channel block (407) having channels (409) therein. Selected reagents are flowed through the channels, the substrate is rotated by a rotating stage (403), and the process is repeated to form arrays of polymers on the substrate. The method may be combined with light-directed methodolgies.Type: GrantFiled: November 22, 1991Date of Patent: January 24, 1995Assignee: Affymax Technologies N.V.Inventors: James L. Winkler, Stephen P. A. Fodor, Christopher J. Buchko, Debra A. Ross, Lois Aldwin
-
Patent number: 5362899Abstract: A stereospecific method of preparing alpha-aminophosphonic acids and derivatives thereof is provided. A protected amino acid is converted to a acyl aroyl or diacyl peroxide which spontaneously rearranges to form an alpha-amino ester. This rearrangement occurs stereospecifically with retention of configuration. The ester is subsequently converted to an appropriate leaving group and displaced with a phosphite yielding a chiral alpha-aminophosphonic acid or derivative.Alpha-aminophosphonic acids are useful for the synthesis of peptide analogs that possess a phosphonate linkage in the place of an amide linkage. This substitution can impart protease resistance in therapeutic peptides thereby increasing the serum half-life.Type: GrantFiled: September 9, 1993Date of Patent: November 8, 1994Assignee: Affymax Technologies, N.V.Inventor: David A. Campbell
-
Patent number: 5338665Abstract: A random peptide library constructed by transforming host cells with a collection of recombinant vectors that encode a fusion protein comprised of a DNA binding protein and a random peptide and also contain a binding site for the DNA binding protein can be used to screen for novel ligands. The screening method results in the formation of a complex comprising the fusion protein bound to a receptor through the random peptide ligand and to the recombinant DNA vector through the DNA binding protein.Type: GrantFiled: October 15, 1992Date of Patent: August 16, 1994Assignee: Affymax Technologies N.V.Inventors: Peter J. Schatz, Willem P. C. Stemmer
-
Patent number: 5302707Abstract: Compositions and methods for producing the activating moiety of a site-directed catalytic antibody are provided. The activating moiety serves to enhance the rate of chemical reactions involving the conversion of the prodrug to one or more active substrates or drugs. The activating moiety typically comprises a catalytic antibody. Compositions and methods for producing the catalytic antibodies, as well as the haptens which are used to generate the catalytic antibodies, are provided. Compositions and methods for producing the prodrugs are also provided.Type: GrantFiled: March 26, 1992Date of Patent: April 12, 1994Assignee: Affymax Technologies N.V.Inventors: David A. Campbell, Mark A. Gallop
-
Patent number: 5270170Abstract: A random peptide library constructed by transforming host cells with a collection of recombinant vectors that encode a fusion protein comprised of a DNA binding protein and a random peptide and also encode a binding site for the DNA binding protein can be used to screen for novel ligands. The screening method results in the formation of a complex comprising the fusion protein bound to a receptor through the random peptide ligand and to the recombinant DNA vector through the DNA binding protein.Type: GrantFiled: October 16, 1991Date of Patent: December 14, 1993Assignee: Affymax Technologies N.V.Inventors: Peter J. Schatz, Millard G. Cull, Jeff F. Miller
-
Patent number: 5264565Abstract: Chimeric G-protein linked receptors are constructed which retain ligand binding specificity yet gain the ability to elevate intracellular free calcium as a result of agonist binding. This easily assayed function is provided by the insertion of or replacement with sequences substantially homologous to the i3 loop of a second G-protein-linked receptor. Such receptors are employed, for example, in methods of screening for compounds capable of acting as agonists or antagonists of G-protein-linked receptors.Type: GrantFiled: January 22, 1991Date of Patent: November 23, 1993Assignee: Affymax Technologies, N.V.Inventors: Bruce P. England, Ronald W. Barrett
-
Patent number: 5252743Abstract: Methods and compositions are described for immobilizing anti-ligands, such as antibodies or antigens, hormones or hormone receptors, oligonucleotides, and polysaccharides on surfaces of solid substrates for various uses. The methods provide surfaces covered with caged binding members which comprise protecting groups capable of being removed upon application of a suitable energy source. Spatially addressed irradiation of predefined regions on the surface permits immobilization of anti-ligands at the activated regions on the surface. Cycles of irradiation on different regions of the surface and immobilization of different anti-ligands allows formation of an immobilized matrix of anti-ligands at defined sites on the surface. The immobilized matrix of anti-ligands permits simultaneous screenings of a liquid sample for ligands having high affinities for certain anti-ligands of the matrix. A preferred embodiment of the invention involves attaching photoactivatable biotin derivatives to a surface.Type: GrantFiled: November 13, 1990Date of Patent: October 12, 1993Assignee: Affymax Technologies N.V.Inventors: Ronald W. Barrett, Michael C. Pirrung, Lubert Stryer, Christopher P. Holmes, Steven A. Sundberg
-
Patent number: 5242974Abstract: A method for cyclization and reversal of the polarity of polymers on a substrate. The method provides for the formation of a polymer on a substrate (2) with a tether molecule (4). Through unmasking of a protective group (PG.sub.2) a cyclic polymer (6) is formed. Through cleavage of an appropriate bond, a polarity reversed polymer (8) is formed. The method finds particular application in the formation of, for example, peptides and oligonucleotides.Type: GrantFiled: November 22, 1991Date of Patent: September 7, 1993Assignee: Affymax Technologies N.V.Inventor: Christopher P. Holmes
-
Patent number: 5143854Abstract: Polypeptide arrays can be synthesized on a substrate by attaching photoremovable groups to the surface of a substrate, exposing selected regions of the substrate to light to activate those regions, attaching an amino acid monomer with a photoremovable group to the activated regions, and repeating the steps of activation and attachment until polypeptides of the desired length and sequences are synthesized. The resulting array can be used to determine which peptides on the array can bind to a receptor.Type: GrantFiled: March 7, 1990Date of Patent: September 1, 1992Assignee: Affymax Technologies N.V.Inventors: Michael C. Pirrung, J. Leighton Read, Stephen P. A. Fodor, Lubert Stryer
-
Patent number: 5142033Abstract: Structure-independent amplification of DNA by the polymerase chain reaction can be achieved by incorporation of 7-deaza-2'-deoxyguanosine-5'-triphosphate into the amplified DNA.Type: GrantFiled: July 31, 1991Date of Patent: August 25, 1992Assignee: Hoffmann-La Roche Inc.Inventor: Michael A. Innis
-
Patent number: 5110920Abstract: HLA typing based on restriction length polymorphism is carried out by: digesting an individual's DNA with a restriction endonuclease that produces a polymorphic digestion pattern with HLA DNA; subjecting the digest to genomic blotting using a labeled DNA hybridization probe that hybridizes to an HLA DNA sequence involved in the polymorphism; and comparing the resulting genomic blotting pattern with a standard. This technique may be adapted to make paternity or transplant or transfusion compatibility determinations or to make disease association correlations to diagnose diseases or predict susceptibility to diseases. Locus specific cDNA hybridization probes, particularly probes for genes of Class II loci, for use in the typing procedure are described.Type: GrantFiled: August 30, 1988Date of Patent: May 5, 1992Assignee: Cetus CorporationInventor: Henry A. Erlich
-
Patent number: 5091310Abstract: Structure-independent amplification of DNA by the polymerase chain reaction can be achieved by incorporation of 7-deaza-2'-deoxyguanosine-5'-triphosphate into the amplified DNA.Type: GrantFiled: September 23, 1988Date of Patent: February 25, 1992Assignee: Cetus CorporationInventor: Michael A. Innis
-
Patent number: 5079351Abstract: The presence or absence of a nucleic acid sequence of an isolate of HTLVI and/or HTLVII in a sample containing one or more nucleic acids and suspected of containing such sequence can be detected by amplifying the sequence using primers to form extension products as templates and detecting the amplified product if it is present. This may be accomplished by adding a labeled hydridization probe to the amplified product, either free in solution or after immobilization on a solid support.Type: GrantFiled: November 26, 1986Date of Patent: January 7, 1992Assignee: Cetus CorporationInventors: John J. Sninsky, Shirley Y. Kwok, Bernard Poiesz
-
Patent number: 5079352Abstract: Recombinant DNA vectors that encode a thermostable DNA polymerase are useful in the recombinant production of thermostable DNA polymerase. The recombinant thermostable polymerase is preferred for use in the production of DNA in a polymerase chain reaction. Especially useful vectors encode the .about.94,000 dalton thermostable DNA polymerase from thermus aquaticus.Type: GrantFiled: May 15, 1990Date of Patent: January 7, 1992Assignee: Cetus CorporationInventors: David H. Gelfand, Susanne Stoffel, Frances C. Lawyer, Randall K. Saiki
-
Patent number: 5075216Abstract: Dideoxynucleotide DNA sequencing methods can be dramatically improved by utilizing the DNA polymerase from Thermus aquaticus to catalyze the primer extension reactions.Type: GrantFiled: September 23, 1988Date of Patent: December 24, 1991Assignee: Cetus CorporationInventors: Michael A. Innis, Kenneth B. Myambo, David H. Gelfand, Mary Ann D. Brow
-
Patent number: 5066584Abstract: Single stranded DNA can be generated by the polymerase chain reaction using two oligonucleotide primers, one persent in a limiting concentration. The single stranded DNA is useful in procedures involving utilizing nucleic acid probes and for purposes of nucleic acid sequencing.Type: GrantFiled: September 23, 1988Date of Patent: November 19, 1991Assignee: Cetus CorporationInventors: Ulf B. Gyllensten, Henry A. Erlich
-
Patent number: 5057410Abstract: The invention provides highly sensitive methods for detecting specific sequences contained in chimeric mRNA. The mRNA sequences are reverse transcribed into complementary DNA (cDNA), amplified by the Polymerase Chain Reaction, and detected by hybridization with a labeled sequence specific oligonucleotide probe. The method is particularly valuable for the detection of chimeric mRNAs experessed by activated oncogenes that result from aberrant genetic rearragements such as chromosomal translocations.Type: GrantFiled: August 5, 1988Date of Patent: October 15, 1991Assignee: Cetus CorporationInventors: Ernest S. Kawasaki, Francis P. McCormick, Owen O. Witto
-
Patent number: 5038852Abstract: There is disclosed herein a machine for performing nucleic acid amplification under computer control. The machine utilizes any one of a number of heating and cooling systems under control of a host computer which directs the heating and cooling systems to heat and cool a reaction-chamber-containing heat exchanger at appropriate times in the process. The reaction chambers are pre-loaded with the nucleic acid(s) to be amplified, a thermostable enzyme to catalyze polymerization, specific oligonucleotide primers, and four different nucleotide triphosphates. Also disclosed is the process for the amplification chain reaction implemented by the machine, which utilizes a thermostable enzyme.Type: GrantFiled: March 14, 1990Date of Patent: August 13, 1991Assignee: Cetus CorporationInventors: Larry J. Johnson, Joseph T. Widunas
-
Patent number: 5008182Abstract: The presence or absence of a nucleic acid sequence associated with AIDS in a sample containing one or more nucleic acids and suspected of containing such sequence can be detected by amplifying the sequence using primers to form extension products as templates and detecting the amplified product if it is present. This may be accomplished by adding a labeled hybridization probe to the amplified product either free in solution or after immobilization on a solid support.Type: GrantFiled: August 15, 1989Date of Patent: April 16, 1991Assignee: Cetus CorporationInventors: John J. Sninsky, Shirley Y. Kwok, David H. Mack
-
Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme
Patent number: 4965188Abstract: A process for amplifying any target nucleic acid sequence contained in a nucleic acid or mixture thereof comprises treating separate complementary strands of the nucleic acid with a molar excess of two oligonucleotide primers and extending the primers with a thermostable enzyme to form complementary primer extension products which act as templates for synthesizing the desired nucleic acid sequence. The amplified sequence can be readily detected. The steps of the reaction can be repeated as often as desired and involve temperature cycling to effect hybridization, promotion of activity of the enzyme, and denaturation of the hybrids formed.Type: GrantFiled: June 17, 1987Date of Patent: October 23, 1990Assignee: Cetus CorporationInventors: Kary B. Mullis, Henry A. Erlich, David H. Gelfand, Glenn Horn, Randall K. Saiki